DEVICE DETAILS
| NAME OF DEVICE | AF531 ORO-NASAL EE FACE MASK |
|---|---|
| ESTABLISHMENT NAME | PHILIPS MALAYSIA SENDIRIAN BERHAD |
| ROLE OF ESTABLISHMENT | AUTHORIZED REPRESENTATIVE |
| REGISTRATION NO | GB4408025-211606 |
| BRAND NAME | PHILIPS RESPIRONICS |
| MEDICAL DEVICE CATEGORY | MD 0100 - GENERAL NON-ACTIVE, NON-IMPLANTABLE MEDICAL DEVICES |
| DEVICE GROUPING TYPE | FAMILY |
| DEVICE DESCRIPTION | The AF531 Oro-Nasal EE Face Mask are devices that have only indirect clinical benefit in that they are used within device systems for the provision of non-invasive ventilation therapy. They do not, by themselves, deliver any therapeutic benefit to patients. The principles of operation and technology for the AF531 Oro-Nasal EE Face Mask have been in use for >35 years to aid treatment of sleep disordered breathing and respiratory insufficiency and failure, and the AF531 Oro-Nasal EE Face Mask detailed in this registration application have been on the market since 2008. The key difference between the Philips AF531 EE Leak 1 and EE Leak 2 elbows lies in the design of the exhalation port: EE Leak 1 (Clear) has a minimal, intentional leak, while EE Leak 2 (Orange) has a built-in leak port for use with specific circuits EE Leak 1: Features a minimal, intentional leak. Not sufficient to eliminate exhaled CO2 from the patient. EE Leak 2: Has a built-in leak port. Can be used without an additional exhalation port. |
| DEVICE INTENDED PURPOSE | Intended Use Medium and Large Size: The AF531 Oro-Nasal EE Leak 1 and 2 Face Mask is intended to provide an interface for application of CPAP or bi-level therapy to patients. The mask is for single use in the hospital/institutional environment only. The mask is to be used on patients (>30 kg) for whom CPAP or bi-level therapy has been prescribed. Small Size: The AF531 Oro-Nasal EE Leak 1 & 2 Face Mask is intended to provide an interface for application of CPAP or bi-level therapy to patients. The mask is for single use in the hospital/institutional environment only. The mask is to be used on patients 7 years or older (>20 kg) for whom CPAP or bi-level therapy has been prescribed. |
| VALIDITY DATE OF REGISTRATION | 18/09/2025 - 17/09/2030 |